Specifically tailored to the Life Sciences Industry this webinar with Shakespeare Martineau will provide insights on how to utilise your IP and related assets during this difficult time for businesses.
More specifically the webinar will cover:
– Brief introduction – what the term “intangible assets” covers by way of intellectual property and related rights (IPRs)
– Commercial exploitation of IPRs
– Determining the content of a business’ IPR portfolio
– Who owns the IPRs created by an employee in the course of his/her employment?
– Who owns the IPRs created by an external consultant or any other third party?
– Types of commercial exploitation in relation to IPRs capable of commercial exploitation
– Assignment including consideration of the main terms that tend to be included in any IPR assignment
– Licensing/sub-licensing
– Securitisation including discussion of the key issues to consider in taking security over IPRs and the nature of the main security interests taken
– Joint ventures including discussion of the key elements to consider in any joint venture project involving IPRs
DURATION: 1 hour
This free to attend webinar will be held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Speaker:
Ed Wright, Partner, Shakespeare Martineau
Ed works with clients from all sectors including life sciences and technology, media and telecoms on wide-ranging non-contentious commercial, contractual, IP, ICT, e-commerce, data protection, competition and public procurement law issues. He advises on IP creation, ownership, protection and exploitation, including technology transfers, R&D collaborations and agency, distribution/reselling and franchising arrangements.
Ed has a keen interest in drafting/advising on IP licensing arrangements and, whenever possible, presents and writes on topical commercial and/or IP matters.
